Literature DB >> 11009171

NICE and drugs for multiple sclerosis. National Institute of Clinical Excellence.

H P Hartung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11009171     DOI： 10.1016/s0140-6736(05)74558-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Principles versus procedures in making health care coverage decisions: addressing inevitable conflicts.

Authors:  Lindsay M Sabik; Reidar K Lie
Journal:  Theor Med Bioeth       Date:  2008-06-06

2.  AP-1 mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon β.

Authors:  Megan L Mittelstadt; Rekha C Patel
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.